• 已选条件：
  • × A683C (rs20576)
 全选  【符合条件的数据共：4条】

1 TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients [期刊论文]

来源：BMC Cancer

作者:Hans Dieter Nischalke;Ulrich Spengler;Jacob Nattermann;等

关键词:Cancer;HCC;...

预览  |  原文链接  |  全文  [ 浏览：1 下载：0  ]    

2 TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients [期刊论文]

来源：BMC Cancer

作者:Hans Dieter Nischalke;Ulrich Spengler;Jacob Nattermann;等

关键词:Cancer;HCC;...

预览  |  原文链接  |  全文  [ 浏览：2 下载：0  ]    

3 TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients [期刊论文]

来源：BMC Cancer , 2012

作者:Thomas Berg;Christian Körner;Andreas Glässner;等

关键词:TRAIL receptor I;DR4;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

4 TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients [期刊论文]

来源：BMC Cancer , 2012

作者:Thomas Berg;Christian Körner;Andreas Glässner;等

关键词:TRAIL receptor I;DR4;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]